Mammogen Appoints Physician Executive and Breast Imaging Leader, Dr. Elise Berman, as Chief Medical Officer

▤ Summary

Mammogen appointed Dr. Elise Berman as Chief Medical Officer to help lead its next stage of growth. The company is advancing genTRU-breast, an RNA-based breast cancer detection platform, through clinical validation and toward commercialization. Dr. Berman brings deep experience in breast imaging, medical affairs, and clinical development, and she previously advised Mammogen on trial design and partnerships. The move follows Mammogen’s $30 million Series A financing and strengthens its clinical and commercialization strategy.

▦ Linked Companies